CRH (CRH) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
16 Jan, 2026Executive summary
Delivered robust Q3 2024 results with 4% revenue growth to $10.5bn, 12% Adjusted EBITDA growth to $2.5bn, and 10% EPS growth, despite significant weather disruptions.
Reaffirmed full-year guidance, supported by strong pricing, disciplined cost management, and positive market dynamics.
Executed $4.6bn in M&A and $1.2bn in divestitures YTD, including major deals in Texas and Australia; integration progressing well.
Ongoing share buyback program ($1.2bn YTD) and new $0.3bn tranche; quarterly dividend of $0.35/share (+5% annualized) declared.
CEO transition announced: Albert Manifold retiring, Jim Mintern appointed as CEO.
Financial highlights
Q3 revenues reached $10.5bn (+4% YoY); 9M revenues at $26.7bn (+2%).
Q3 Adjusted EBITDA was $2.5bn (+12% YoY), with margin expansion of 170bps to 23.3%.
Q3 EPS was $1.99 (+10% YoY); 9M EPS at $4.03 (+20% YoY).
Declared a new quarterly dividend of $0.35/share, annualized increase of 5%.
Organic Adjusted EBITDA growth of $180m (+8%) in Q3; acquisitions net of divestitures added $79m.
Outlook and guidance
Full-year 2024 Adjusted EBITDA expected between $6.87bn and $6.97bn; net income $3.78bn–$3.85bn; EPS $5.45–$5.55.
Capital expenditure guidance for 2024 raised to $2.4bn–$2.6bn.
Positive momentum expected to continue into 2025, with infrastructure and non-residential demand underpinned by public funding and robust international markets.
Anticipates gradual improvement in new-build residential activity in H2 2025, assuming interest rates normalize.
Potential Q4 impairment in the range of $0.3–$0.4bn not reflected in current guidance.
Latest events from CRH
- Record financials, capital structure simplification, and key governance proposals for 2026 AGM.CRH
Proxy Filing13 Mar 2026 - Delisting and preference share cancellations aim to simplify capital structure and cut costs.CRH
Proxy Filing13 Mar 2026 - Record 2025 financials, double-digit EBITDA growth, and strong 2026 outlook on infrastructure demand.CRH
Q4 202519 Feb 2026 - Q2 net income up 8%, EBITDA up 12%, margins expanded, and FY24 guidance raised.CRH
H1 20242 Feb 2026 - Double-digit profit growth and margin expansion achieved, with strong 2025 outlook.CRH
H2 20247 Jan 2026 - Record Q3, raised FY25 EBITDA guidance, and strong outlook driven by demand and acquisitions.CRH
Q3 2025 TU21 Dec 2025 - Record financials, new equity plan, governance updates, and strong ESG progress headline the proxy.CRH
Proxy Filing2 Dec 2025 - Record results, NYSE transition, new CEO, and 12 key AGM proposals mark a transformative year.CRH
Proxy Filing2 Dec 2025 - Definitive additional proxy materials filed for upcoming shareholder meeting.CRH
Proxy Filing2 Dec 2025